AI assistant
Sending…
Sanofi — Director's Dealing 2019
Jan 22, 2019
1643_dirs_2019-01-22_e6c2961e-9703-4efe-9b26-078e1ac40223.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: ALNYLAM PHARMACEUTICALS, INC. (ALNY)
CIK: 0001178670
Period of Report: 2019-01-17
Reporting Person: Sanofi (10% Owner)
More from Sanofi
Share Issue/Capital Change
2026
Jun 4
Share Issue/Capital Change
2026
Jun 4
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 28
Regulatory Filings
2026
May 28
Report Publication Announcement
2026
May 27
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 19
Regulatory Filings
2026
May 18
Capital/Financing Update
2026
May 18